- The market for vascular grafts and peripheral stents is growing steadily, reflecting increased adoption of advanced medical devices in cardiovascular treatments. Innovations in design and materials are enhancing the safety and effectiveness of these products, making them preferred options in clinical settings
- Manufacturers are focusing on expanding product portfolios with improved durability and biocompatibility to meet evolving patient needs. The integration of cutting-edge technology is also streamlining procedures and supporting better patient outcomes
- North America dominates and holds the largest revenue share in the vascular grafts and peripheral stents market in 2024, driven by the high prevalence of cardiovascular diseases and a well-established healthcare infrastructure
- Asia-Pacific region is expected to witness the highest growth rate in the global vascular grafts and peripheral stents market, driven by rising healthcare expenditures, growing awareness of vascular diseases, and expanding elderly populations across countries such as China, India, and Japan
- The vascular graft segment holds a dominant market share in 2024 due to its extensive use in bypass surgeries and vascular reconstructions. These grafts are essential for restoring blood flow in blocked or damaged vessels, particularly in coronary and peripheral arteries
